# Luigi F. Bertoli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luigi-f-bertoli/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,529 |
| Field | Immunodeficiency and Autoimmune Disorders |
| h-index | 20 |
| i10-index | 31 |
| OpenAlex ID | https://openalex.org/A5112066639 |
| Works | 61 |

## Researcher papers

- [Identity of the elusive IgM Fc receptor (FcμR) in humans](https://scholariq.org/papers/identity-of-the-elusive-igm-fc-receptor-fc-r-in-humans/)
- [Iron overload in African Americans](https://scholariq.org/papers/iron-overload-in-african-americans/)
- [Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation](https://scholariq.org/papers/intravenous-iron-dextran-therapy-in-patients-with-iron-deficiency-and-normal/)
- [Peripheral blood erythrocyte parameters in hemochromatosis: Evidence for increased erythrocyte hemoglobin content](https://scholariq.org/papers/peripheral-blood-erythrocyte-parameters-in-hemochromatosis-evidence-for/)
- [Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin](https://scholariq.org/papers/acute-cryoglobulinemic-renal-failure-after-intravenous-infusion-of-gamma/)
- [Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5](https://scholariq.org/papers/tumor-suppression-by-phospholipase-c-3-via-shp-1-mediated-dephosphorylation-of/)
- [Genotypic and phenotypic heterogeneity of African Americans with primary iron overload](https://scholariq.org/papers/genotypic-and-phenotypic-heterogeneity-of-african-americans-with-primary-iron/)
- [Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients](https://scholariq.org/papers/pica-associated-with-iron-deficiency-or-depletion-clinical-and-laboratory/)
- [AN ANTIBODY THAT INHIBITS IN VITRO BONE MARROW PROLIFERATION IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND APLASTIC ANEMIA](https://scholariq.org/papers/an-antibody-that-inhibits-in-vitro-bone-marrow-proliferation-in-a-patient-with/)
- [Phase II Trial of Alfimeprase, a Novel-Acting Fibrin Degradation Agent, for Occluded Central Venous Access Devices](https://scholariq.org/papers/phase-ii-trial-of-alfimeprase-a-novel-acting-fibrin-degradation-agent-for/)
- [Intravenous Bevacizumab Therapy in a Patient with Hereditary Hemorrhagic Telangiectasia, ENG E137K, Alcoholic Cirrhosis, and Portal Hypertension](https://scholariq.org/papers/intravenous-bevacizumab-therapy-in-a-patient-with-hereditary-hemorrhagic/)

## Researcher topics

- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.